These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 5023257

  • 1. Serum protein-bound fucose in patients with gynecologic cancers.
    Barlow JJ, Dillard PH.
    Obstet Gynecol; 1972 May; 39(5):727-34. PubMed ID: 5023257
    [No Abstract] [Full Text] [Related]

  • 2. Serum fucose levels in gynaecological disorders including carcinoma cervix.
    Bandlish U, Prabhakar BR, Virmani U.
    J Indian Med Assoc; 1991 Sep; 89(9):250-1. PubMed ID: 1795106
    [Abstract] [Full Text] [Related]

  • 3. [Monitoring the course of malignant neoplasms of the genital organs in women by means of determination of blood serum level of fucose, sialic acid, CEA and AFP].
    Simm S, Markowska J, Tomaszkiewicz T, Herwichowska K, Breborowicz J.
    Ginekol Pol; 1979 Dec; 50(12):1029-36. PubMed ID: 94024
    [No Abstract] [Full Text] [Related]

  • 4. [A critical study on the differentiation of the acceleration of the erythrocyte sedimentation rate due to tumorous and inflammatory processes in diseases of the female genitalia].
    Schander K.
    Z Geburtshilfe Gynakol; 1969 Dec; 170(1):73-7. PubMed ID: 5794762
    [No Abstract] [Full Text] [Related]

  • 5. [Preliminary evaluation of the usefulness of determination of blood serum fucose and sialic acid level in women with genital tumors].
    Simm S, Markowska J, Tomaszkiewicz T, Herwichowska K.
    Ginekol Pol; 1979 Nov; 50(11):957-63. PubMed ID: 544355
    [No Abstract] [Full Text] [Related]

  • 6. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
    von Tempelhoff GF, Nieman F, Heilmann L, Hommel G.
    Clin Hemorheol Microcirc; 2000 Nov; 22(2):107-30. PubMed ID: 10831062
    [Abstract] [Full Text] [Related]

  • 7. Seromucoid in serum in benign and malignant gynaecological disorders.
    Randle GH, Good W, Cumberbatch KN.
    J Obstet Gynaecol Br Commonw; 1974 Jun; 81(6):479-82. PubMed ID: 4407083
    [No Abstract] [Full Text] [Related]

  • 8. [Plasmatic glycoproteins in malignant neoplasms of the female genital system].
    Torre GC, Salvatores D, Azzarini V.
    Arch Ostet Ginecol; 1970 Jun; 75(1):78-92. PubMed ID: 5459103
    [No Abstract] [Full Text] [Related]

  • 9. [Biochemical findings in malignant neoplasms of the female genital organs].
    Koshkina SI, Makarov KS, Shiferson RG, Pchelkin EI, Zelentsovskaia GP.
    Vopr Onkol; 1967 Jun; 13(1):107. PubMed ID: 4176512
    [No Abstract] [Full Text] [Related]

  • 10. [Variations in the level of immunosuppressive acidic protein in patients with gynecologic tumors and pregnant women].
    Sawada M, Okudaira Y, Matsui Y, Miyoshi Y, Takayama K, Shimizu Y, Miura S.
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1823-30. PubMed ID: 6882005
    [Abstract] [Full Text] [Related]

  • 11. [Plasma fibrinogen in female patients with genital cancer and its early stage].
    Lober R, Krantz S, Lober M.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985 Aug; 112(1):71-81. PubMed ID: 2581873
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of serum ferritin in female genital neoplasms].
    Dong MY.
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):21-3, 61. PubMed ID: 1848498
    [Abstract] [Full Text] [Related]

  • 13. [Serum levels of a immunosuppressive acidic protein in patients with gynecological cancer (author's transl)].
    Suzuki H, Miyoshi T, Sasaki H, Yoshida T.
    Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):513-8. PubMed ID: 6785990
    [No Abstract] [Full Text] [Related]

  • 14. [Induction of M-CSF and G-CSF receptor mRNA in peripheral blood mononuclear cells of gynecological cancer by sizofiran].
    Hoshino T, Suzuki Y, Adachi T, Yagishita M, Takayama M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Jul; 45(7):677-8. PubMed ID: 8340649
    [No Abstract] [Full Text] [Related]

  • 15. [Value of N-acetylneuraminic acid (NANA) in the serum of patients with gynecologic cancers].
    Schrempel A, Kürschner M.
    Zentralbl Gynakol; 1985 Jul; 107(3):175-8. PubMed ID: 3984572
    [Abstract] [Full Text] [Related]

  • 16. [Transient form of serum albumin in gynecologic cancer].
    Rybalka AN, Bagdasar'ian SN, Garina TN, Karpilenko TM, Kasymova GA.
    Biull Eksp Biol Med; 1984 Jan; 97(1):76-9. PubMed ID: 6692030
    [Abstract] [Full Text] [Related]

  • 17. Disseminated intravascular coagulation in gynecologic cancer.
    Lifshitz S, Buchsbaum HJ.
    Obstet Gynecol; 1975 Nov; 46(5):607-10. PubMed ID: 1196568
    [Abstract] [Full Text] [Related]

  • 18. [The serum copper/serum iron ratio in malignant tumors of the female genitalia].
    Maas DH, Hinckers HJ.
    Geburtshilfe Frauenheilkd; 1975 Aug; 35(8):619-26. PubMed ID: 1175904
    [Abstract] [Full Text] [Related]

  • 19. Serum copper alterations in genital cancer.
    O'Leary JA, Feldman M.
    Surg Forum; 1970 Aug; 21():411-2. PubMed ID: 5514783
    [No Abstract] [Full Text] [Related]

  • 20. Serum protein bound fucose in diagnosis of breast malignancy.
    Solanki RL, Ramdeo IN, Sachdev KN.
    Indian J Med Res; 1978 May; 67(5):786-91. PubMed ID: 680922
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.